Have a personal or library account? Click to login
Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab Cover

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

Radiology and Oncology
Volume 48 (2014): Issue 2 (June 2014)
By: Robert Königsberg,  Julia Maierhofer,  Tanja Steininger,  Gabriele Kienzer and  Christian Dittrich  
Open Access
|Apr 2014

Metrics

DOI: https://doi.org/10.2478/raon-2013-0083 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 184 - 188
Submitted on: Aug 27, 2013
Accepted on: Nov 18, 2013
Published on: Apr 25, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
breast cancer,
Her2/neu,
trastuzumab,
bevacizumab,
VEGF
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Robert Königsberg, Julia Maierhofer, Tanja Steininger, Gabriele Kienzer, Christian Dittrich, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 48 (2014): Issue 2 (June 2014)Next article